ArticleCEN case reports2026
An autopsy-proven case of normotensive scleroderma renal crisis with refractory pleuroperitoneal effusion.
Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionScleroderma renal crisis (SRC) is a serious complication of systemic sclerosis that typically presents with hypertension and acute kidney injury (AKI). However, about 10% of cases are normotensive, while refractory pleural or ascitic effusion preceding SRC is rare in clinical practice. Here, we present a case of normotensive SRC preceded by refractory pleural and ascitic effusions. CASE PRESENTATION: The patient was a 66-year-old woman with a history of rheumatoid arthritis who was managed as an outpatient. Three months prior to admission, she developed sudden, generalized refractory pleural and ascitic effusions; however, the cause remained unknown and there was no improvement. Subsequently, she developed AKI and was transferred to our hospital. Hemodialysis was initiated, but despite efforts to reduce dry weight, transudative pleural effusion persisted. The patient was positive for anti-SCL-70 antibodies, but had no hypertension, and a kidney biopsy could not be performed. She later developed pneumonia and ultimately died of respiratory failure caused by pneumonia and pleural effusion. An autopsy revealed widespread fibrosis in multiple organs and marked intimal thickening and stenosis of the vasculature, leading to a diagnosis of normotensive SRC.
conclusionIt is important to consider normotensive SRC as a potential cause of refractory transudative pleural and ascitic effusions resistant to treatment with hemodialysis associated with AKI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.